TITLE

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

AUTHOR(S)
Kelland, N. F.; Webb, D. J.
PUB. DATE
January 2007
SOURCE
Heart;Jan2007, Vol. 93 Issue 1, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors discusses the benefits of the publication of all clinical trials concerning endothelin antagonists in heart failure. The role of endothelin-1(ET-1) in experimental heart failure reveals its amelioration of the left ventricular dysfunction, its prevention of ventricular remodeling and survival after coronary heart litigation.
ACCESSION #
23638000

 

Related Articles

  • Nesiritide for outpatient treatment of heart failure. Bauer, Jered B.; Randazzo, Michael A. // American Journal of Health-System Pharmacy;12/15/2005, Vol. 62 Issue 24, p2639 

    The article presents a study on the outpatient use of nesiritide to minimize patient admission suffering from chronic heart failure in the U.S. A statistical report on the cost of medication for the treatment of heart failure is presented. Several clinical trials have found nesiritide to be safe...

  • Adjunctive treatment with eplerenone reduced 30 day all cause mortality in acute myocardial infarction. Pitt, B.; White, H.; Nicolau, J. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p14 

    The article reports on a study to determine whether adjunctive treatment with eplerenone can decrease morbidity and mortality better than placebo in patients with acute myocardial infarction (AMI) with left ventricular systolic dysfunction (LVSD) and heart failure. A randomized placebo...

  • Clinical brief.  // New Zealand Doctor;6/2/2004, p21 

    Reports on a research which tested a cardiac resynchronization therapy device for heart failure patients, which was published in the 2004 issue of "New England Journal of Medicine." Classification of clinical trial patients; Implications of the study's findings for heart failure treatment.

  • Trastuzumab and Congestive Heart Failure: What Can We Learn From Use in the Community? Geiger, Ann M. // JNCI: Journal of the National Cancer Institute;9/5/2012, Vol. 104 Issue 17, p1269 

    The author reflects on what can be learned from the study on the association of trastuzumab with congestive heart failure among women treated outside clinical trials. She examines the median follow-up time, and the design of treatment and comparison arms in randomized controlled trials. She...

  • Study to Test Exercise in Heart Failure Patients.  // IDEA Fitness Journal;May2007, Vol. 4 Issue 5, p15 

    This article announces that a randomized clinical trial of exercise training is underway which will involve 83 sites that will test 3,000 people to find out whether exercise is good for hearth failure patients. It says that health and fitness promoters may benefit from this undertaking. Delane...

  • A systematic review of the mediating role of knowledge, self-efficacy and self-care behaviour in telehealth patients with heart failure. Ciere, Yvette; Cartwright, Martin; Newman, Stanton P. // Journal of Telemedicine & Telecare;Oct2012, Vol. 18 Issue 7, p384 

    We conducted a systematic review of controlled trials and pre-post studies to examine whether the putative benefits of telehealth, notably, improvements in clinical outcomes and quality of life, are mediated by increases in knowledge, self-efficacy and self-care behaviour in patients with heart...

  • Is There Such a Thing as Diastolic Heart Failure? Zepf, Bill // American Family Physician;1/15/2005, Vol. 71 Issue 2, p374 

    Discusses research being done on diastolic heart failure. Reference to a study by M. R. Zile et al published in the May 6, 2004 issue of the "New England Journal of Medicine"; Number of study participants; Key indicators of diastolic function; Left ventricle abnormalities associated with...

  • Adverse-event profile of Crataegus spp.: a systematic review. Daniele, Claudia; Mazzanti, Gabriela; Pittler, Max H.; Ernst, Edzard // Drug Safety;2006, Vol. 29 Issue 6, p523 

    Crataegus spp. (hawthorn) monopreparations are predominantly used for treating congestive heart failure. The effectiveness of hawthorn preparations (flowers with leaves; berries) is documented in a number of clinical studies, reviews and meta-analyses. The aim of this article is to assess the...

  • Commentary. Moyer, Carey D.; Berger, Peter B. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p14 

    The article comments on a study by B. Pitt and colleagues to determine whether adjunctive treatment with eplerenone can decrease morbidity and mortality better than placebo in patients with acute myocardial infarction (AMI) with left ventricular systolic dysfunction (LVSD) and heart failure. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics